cloning and expression of functional reteplase in escherichia coli top10
Authors
abstract
background: production of tissue plasminogen activator protein (t-pa) in prokaryotes systems has many problems such as the lack of active protein production, multiple purification steps, and renaturation process which has been shown to be costly and time-consuming. methods: in this study, reteplase which is the nonglycosylated active domain of t-pa was used to transform top10 escherichia coli (e. coli) bacteria to resolve some of the above mentioned problems. reteplase cdna was ligated into pbad/giii plasmid which allowed secretion of this protein into the periplasmic space and would allow the correct formation of disulfide bonds in protein structure. the presence of reteplase cdna in pbad/giii plasmid was confirmed by restriction digestion and sequencing. after induction of the expression of this protein by adding 0.0002% l-arabinose to the medium, the proteins in periplasmic space as well as the inclusion bodies formed inside the cell were extracted. subsequently, these proteins were purified and detected by western blot method. results: our results showed that the amount of reteplase extracted from periplasmic space was much lower than the extracted inclusion bodies and large quantities of the recombinant protein were present as inclusion bodies. therefore, it was more efficient to use inclusion body extraction method for protein isolation and purification. conclusion: we produced active reteplase after its expression in e. coli top10 and isolation of inclusion bodies produced the best results for purification and extraction of this protein.
similar resources
Cloning and Expression of Functional Reteplase in Escherichia coli TOP10
BACKGROUND Production of tissue Plasminogen Activator protein (t-PA) in prokaryotes systems has many problems such as the lack of active protein production, multiple purification steps, and renaturation process which has been shown to be costly and time-consuming. METHODS In this study, reteplase which is the nonglycosylated active domain of t-PA was used to transform TOP10 Escherichia coli (...
full textexpression and activity evaluation of reteplase in escherichia coli top10
reteplase is a part of tissue plasminogen activator (t-pa) used for theremoval of thrombi in blood vessels. in the present study we express the reteplase genein escherichia coli top10 and then its thrombolytic activity was measured. the recombinant plasmid pbadgiiia was transformed into the competent escherichia coli top10 and then transformed bacteria was seeded into bioreactor containing 1.5 ...
full textOptimization of the Expression of Reteplase in Escherichia coli TOP10 Using Arabinose Promoter
BACKGROUND Reteplase is a mutant version of t-PA (tissue plasminogen activator) with prolonged half-life. In the present study, E. coli Top 10 bacteria were utilized in the production of reteplase, which is the nonglycosylated active domain of t-PA. Reteplase gene was ligated into pBAD/gIII plasmid which, allows secretion of this protein in periplasmic space. It would allow the correct formatio...
full textoptimization of the expression of reteplase in escherichia coli top10 using arabinose promoter
conclusions reteplase was expressed in e. coli top 10 after activation of pbad/giiia promoter region by arabinose and optimized. results the obtained recombinant plasmid was sequenced to confirm the presence and correct framing of reteplase gene regarding the expression of reteplase. maximum production of this enzyme was obtained under the following condition: 0.0002% l-arabinose at 37°c for 2 ...
full textCloning and Expression of Mannheimia haemolytica PlpE Gene in Escherichia coli and its Immunogenicity Assessment
Mannheimia haemolytica is responsible for considerable economic losses to cattle, sheep, and goat industries in many parts of the world. This bacterium isone of the causative agents of shipping fever in cattle. Current vaccines against M. haemolytica are moderately efficacious since they do not provide complete protection against the disease. Production of a...
full textMy Resources
Save resource for easier access later
Journal title:
avicenna journal of medical biotechnologyجلد ۵، شماره ۳، صفحات ۱۶۸-۱۷۵
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023